鸿茅药酒品牌怎么样 申请店铺

我要投票 鸿茅药酒在保健酒行业中的票数:12 更新时间:2024-11-22
鸿茅药酒是哪个国家的品牌?「鸿茅药酒」是内蒙古鸿茅国药股份有限公司旗下著名品牌。该品牌发源于内蒙古,由创始人鲍洪升在2002期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
鸿茅药酒怎么样

内蒙古鸿茅药业有限责任公司成立于2002年,其前身为内蒙古凉城县鸿茅酒厂。公司现有职工300余名,总资产超过2亿,生产基地占地280余亩,拥有药酒、保健酒等多个品种。

公司主营产品“鸿茅药酒”,始创于1739年(清乾隆四年),距今已经有近三百年的历史。曾作为宫廷贡酒,被封为皇室养生益寿的御用圣品,传承数百年药用历史,成为中华医药的瑰宝,并入选国家“非物质文化遗产名录”。

2011年,中华人民共和国商务部授予鸿茅为“中华老字号”;2011年,国家工商行政管理总局认定鸿茅为“驰名保护”;2014年“鸿茅药酒配制技艺”入选国务院批准文化部确定的《第四批非物质文化遗产代表性项目名录》。

新一代鸿茅人谨遵“良药济世,精工取繁”的百年祖训,结合传统“八步古法酿造工艺”和现代高科技萃取技术,创新开发出符合GMP标准的现代化工艺—20级精制法,不断提升药酒的品质,从源头上保证消费者的权益。

“使命民族企业,成就中华瑰宝”是鸿茅药业的企业发展理念,以文化为先导,以品质为核心,鸿茅药业坚守“仁、道、信、义、至善”的核心价值观,全面提升企业的新技艺研发能力,推动创新实效的企业运营模式,通过持续的品牌建设和创新营销,践行“百年鸿茅”的企业目标,做中医药文化的传播者。

新时期的鸿茅人正意气奋发地投身搏击于中国的经济大潮,依托于健康中国的发展机遇,以更加成就稳健的姿态去迎接这个神圣而艰巨的挑战,续写“百年鸿茅”品牌更辉煌的未来!

Inner Mongolia Hongmao Pharmaceutical Co., Ltd. was founded in 2002, its predecessor is Inner Mongolia Liangcheng Hongmao distillery. The company has more than 300 employees, a total assets of more than 200 million, a production base covering an area of more than 280 mu, with a variety of medicine wine, health wine and so on. The company's main product, "Hongmao medicinal wine", was founded in 1739 (the fourth year of Qianlong in the Qing Dynasty). It has a history of nearly 300 years. As a royal tribute wine, it was awarded as a Royal Saint for health preservation and longevity, inheriting hundreds of years of medicinal history, becoming a treasure of Chinese medicine and listed in the national intangible cultural heritage list. In 2011, the Ministry of Commerce of the people's Republic of China Awarded Hongmao as the "time-honored brand of China"; in 2011, the State Administration for Industry and Commerce recognized Hongmao as "well-known protection"; in 2014, "Hongmao liquor preparation technology" was selected into the "fourth batch of Intangible Cultural Heritage Representative project list" approved by the Ministry of culture. A new generation of Hongmao people, following the centenary motto of "good medicine for the world, precision work for the complex", combined with the traditional "eight step ancient brewing process" and modern high-tech extraction technology, have innovated and developed a modern process - 20 level refining process that meets the GMP standard, constantly improving the quality of medicinal wine, and ensuring the rights and interests of consumers from the source. "Mission of national enterprises, achievement of Chinese treasures" is Hongmao pharmaceutical's enterprise development concept, taking culture as the guide, quality as the core, Hongmao pharmaceutical adheres to the core values of "benevolence, Taoism, faith, righteousness, and supreme goodness", comprehensively improves the enterprise's new technology research and development ability, promotes the innovative and effective enterprise operation mode, and practices "one hundred years" through continuous brand building and innovative marketing Hongmao "aims to be a disseminator of traditional Chinese medicine culture. In the new era, Hongmao people are devoting themselves to the economic tide of China, relying on the development opportunity of healthy China, meeting this sacred and arduous challenge with a more stable attitude of achievement, and continuing to write a more brilliant future of "Hongmao" brand!

本文链接: https://brand.waitui.com/331f518f1.html 联系电话:0474-4865222

千城特选小程序码

7×24h 快讯

私募购买年内上市ETF近30亿份

私募排排网统计数据显示,截至11月22日,共有126家私募证券管理人旗下产品进入到107家年内上市ETF前十大持有人名单中,合计持有份额达29.57亿份。(界面)

2小时前

外交部:进一步扩大免签国家范围并优化入境政策

36氪获悉,据外交部领事司,为进一步便利中外人员往来,中方决定扩大免签国家范围,自2024年11月30日起至2025年12月31日,对保加利亚、罗马尼亚、克罗地亚、黑山、北马其顿、马耳他、爱沙尼亚、拉脱维亚、日本持普通护照人员试行免签政策。此外,中方决定同步优化入境政策,将交流访问纳入免签事由,将免签停留期限自现行15日延长至30日。自2024年11月30日起,包括上述9国在内的38个免签国家持普通护照人员来华经商、旅游观光、探亲访友、交流访问、过境不超过30天,可免办签证入境。不符合免签条件人员仍需在入境前办妥来华签证。

2小时前

中国汽车流通协会:预计11月狭义乘用车零售市场约为240万辆

36氪获悉,据中国汽车流通协会,最新调研结果显示,11月月中整体车市折扣率约为24.1%,环比上月基本持平,终端优惠及促销政策力度无明显变化。零售量占总市场近八成的头部厂商本月零售目标环比增幅约6.5%,初步推算本月狭义乘用车零售总市场规模约为240.0万辆左右,同比去年增长15.4%,环比上月增长6.1%,新能源零售预计可达128.0万,渗透率约53.3%。

2小时前

越南电动车商VinFast母公司成立机器人研发应用企业VinRobotics

当地时间11月20日,越南电动车商VinFast母公司Vin集团宣布成立“VinRobotics机器人研发与应用股份公司”,法定资本为10万亿越南盾(约合4000万美元)。Vin集团持有新公司51%的股份,Vin集团创始人范日旺持股39%。(界面)

2小时前

康为世纪:幽门螺杆菌耐药基因检测试剂盒获得III类医疗器械注册证

36氪获悉,康为世纪发布公告,全资子公司健为诊断自主研发生产的幽门螺杆菌耐药基因检测试剂盒(基于粪便样本)收到国家药品监督管理局颁发的III类《医疗器械注册证》。

2小时前

本页详细列出关于鹿司令的品牌信息,含品牌所属公司介绍,鹿司令所处行业的品牌地位及优势。
咨询